Enavate Sciences Invests in Braveheart Bio’s $185 Million Series A Financing

Leila Ahmed North America Legal Chronicle
Tagged:

Wilmer Cutler Pickering Hale and Dorr has advised Enavate Sciences. Goodwin Procter has advised Braveheart Bio. Enavate Sciences, a platform of Patient Square Capital, has made…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here